Peter Soparkar

CIK 1736315 · CHIEF OPERATING OFFICER · last filed 2025-12-10

Peter Soparkar is a CHIEF OPERATING OFFICER who has filed 20 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for ADVM, was dated Dec 10, 2025. Across all open-market trades the lifetime net is +$353.1K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

20

Lifetime Open-Market Net

$353.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Adverum Biotechnologies, Inc. (ADVM) Delisted CHIEF OPERATING OFFICER 0 $4.36 $0 $353.1K 20 2025-12-10

Recent Filings

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-10 Adverum Biotechnologies, Inc. (ADVM) Delisted Mixed −100,647 $0 EDGAR
2025-12-08 Adverum Biotechnologies, Inc. (ADVM) Delisted Buy (P) +50,000 $211.0K EDGAR
2025-06-20 Adverum Biotechnologies, Inc. (ADVM) Delisted Mixed $0 EDGAR
2025-05-16 Adverum Biotechnologies, Inc. (ADVM) Delisted Sell (S) −2,960 -$5.9K EDGAR
2025-02-27 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) +13,125 $0 EDGAR
2024-08-06 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
2024-03-12 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
2024-02-14 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
2023-03-17 Adverum Biotechnologies, Inc. (ADVM) Delisted Sell (S) −13,360 -$10.4K EDGAR
2023-03-03 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
Showing 110 of 20
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.